Wedge Networks announces general availability of its innovative, Continuous Learning Analytics and Threat Intelligence Engine, WedgeIQ™ Nucleation Edition at Asia Tech Singapore

يونيو 6, 2023

Wedge Networks (Wedge) today announced the General Availability (GA) of WedgeIQ™ Nucleation Edition, an innovative, continuous machine-learning based Security Operations, Incident, and Event Management (SIEM) and analytics engine, at Asia Tech x Singapore, Asia’s premier tech event. Developed as a licensable component of the advanced WedgeARP™ software platform, WedgeIQ™ Nucleation Edition offers a potent response to today’s pressing cybersecurity challenges, particularly the increasingly sophisticated, never-before-seen malware that outmaneuvers current defense systems where Wedge’s patented continuous AI engines are continuously learning to respond to such attacks.

Biotricity, News

Biotricity reaches $13M revenue run rate in April 2023 on accelerating growth

مايو 16, 2023

Biotricity Inc. (Biotricity) today reported that it reached a record $13 million annualized revenue run rate in April, further extending its growth by over eight percent from the $12 million run rate it announced for March 2023. In its Corporate Impact Report published earlier this month, Biotricity described both “better patient outcomes and substantial cost savings” for patients using its devices.

News, Wedge Networks

Wedge Networks teams up with Edgecore Networks to offer next-generation network security WedgeCND™ Add-on now available on Edgecore ecCLOUD

مايو 8, 2023

Wedge Networks Inc. (“Wedge”) today announced that Edgecore Networks, a leading provider of traditional and open network solutions for enterprises, data centers, and telecommunication service providers, has partnered with Wedge Networks to offer a next-generation network security solution to its customers. Wedge Networks’ Wedge Cloud Network Defense (WedgeCND™), is a cloud-managed security service designed to provide comprehensive security protection.

Biotricity, Financial Results

Biotricity reaches $12M revenue run rate in March with promising future growth ahead

أبريل 19, 2023

Biotricity Inc. (Biotricity) reported that it reached a record $12 million annualized revenue run rate in March 2023. Based on preliminary month-to-date results and internal projections, the Company remains excited regarding potential top line revenue growth in April and the current quarter (Q4FY23) as it maintains optimized investment in R&D, sales and marketing. The Company attributed its strengthening financials to the growing sales of its product line of remote cardiac monitors spanning consumers to cardiologists, the ramp up of its subscription-based recurring service revenues, and the early success of its recently expanded distribution strategy.

Biotricity, الرعاية الصحية

Biotricity releases first corporate impact report

أبريل 11, 2023

Biotricity Inc. (Biotricity) has released its first has released its first Corporate Impact Report– revealing that the company’s remote, clinical-grade diagnostic devices are inducing “better patient outcomes and substantial cost savings” across the nation. Presenting new data, the report highlights specific examples of Biotricity’s impact on “reforming the healthcare market by bridging the gap between effective remote diagnostics, remote patient monitoring and chronic care management.”

Biotricity, Financial Results

Biotricity reports financial results for Fiscal 2023 Third Quarter

فبراير 14, 2023

Biotricity Inc. (Biotricity) today announced its financial results and provided a business update for its third quarter of fiscal 2023 ended December 31, 2022. Commenting, Dr. Waqaas Al-Siddiq, Biotricity Founder & CEO, said, “With our suite of state-of-the-art remote cardiac solutions now well established, Biotricity is focused on sales, marketing and achieving positive cash flow.”

الأخبار الصحفية